Up a level |
(2015) A prospective crossover triple-blind controlled trial on the safety and efficacy of Iranian recombinant FVIII (Safacto®) versus plasma derived FVIII; a pilot study. Iranian Journal of Blood and Cancer. pp. 171-174. ISSN 20084595 (ISSN)